Alyeska Investment Group Portfolio holdings
AUM
$28.2B
1-Year Return
38.86%
This Quarter Return
-2.3%
1 Year Return
+38.86%
3 Year Return
+101.95%
5 Year Return
+160.93%
10 Year Return
+424.53%
AUM
$25B
AUM Growth
-$1.57B
(-5.9%)
Cap. Flow
-$922M
Cap. Flow
% of AUM
-3.69%
Top 10 Holdings %
Top 10 Hldgs %
22.22%
Holding
695
New
157
Increased
139
Reduced
161
Closed
203
Top Buys
| 1 |
Amazon
AMZN
|
$494M |
| 2 |
Microsoft
MSFT
|
$376M |
| 3 |
Salesforce
CRM
|
$265M |
| 4 |
Electronic Arts
EA
|
$225M |
| 5 |
AT&T
T
|
$217M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
$833M |
| 2 |
Alibaba
BABA
|
$479M |
| 3 |
Meta Platforms (Facebook)
META
|
$398M |
| 4 |
Boeing
BA
|
$328M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$321M |
Sector Composition
| 1 | Technology | 21.48% |
| 2 | Consumer Discretionary | 12.61% |
| 3 | Healthcare | 10.38% |
| 4 | Industrials | 10.15% |
| 5 | Real Estate | 8.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DEC
376
Diversified Energy
DEC
$1.16B
| $3.74M | 0.01% |
276,740
+199,387
| +258% | +$2.7M |
|
|
LENZ
377
LENZ Therapeutics
LENZ
$1.2B
| $3.65M | 0.01% |
142,113
| – | – |
|
378
ARS Pharmaceuticals
SPRY
$995M
| $3.65M | 0.01% |
290,092
-963,632
| -77% | -$12.1M |
|
379
Nuvalent
NUVL
$5.83B
| $3.64M | 0.01% |
51,303
-51,302
| -50% | -$3.64M |
|
380
NiSource
NI
$19B
| $3.58M | 0.01% |
89,313
+8,919
| +11% | +$358K |
|
381
Vestis
VSTS
$601M
| $3.56M | 0.01% |
359,694
-1,333,549
| -79% | -$13.2M |
|
382
Southern Company
SO
$101B
| $3.52M | 0.01% |
+38,230
| New | +$3.52M |
|
383
GDS Holdings
GDS
$6.35B
| $3.48M | 0.01% |
137,253
+8,075
| +6% | +$205K |
|
384
Aligos Therapeutics
ALGS
$78.8M
| $3.4M | 0.01% |
+412,000
| New | +$3.4M |
|
385
Apellis Pharmaceuticals
APLS
$3.55B
| $3.28M | 0.01% |
+150,000
| New | +$3.28M |
|
|
OKLO
386
Oklo
OKLO
$10.3B
| $3.24M | 0.01% |
150,000
-1,056,281
| -88% | -$22.8M |
|
|
INN
387
Summit Hotel Properties
INN
$614M
| $3.24M | 0.01% |
598,819
| – | – |
|
388
Eledon Pharmaceuticals
ELDN
$162M
| $3.16M | 0.01% |
933,475
| – | – |
|
389
Larimar Therapeutics
LRMR
$337M
| $3.1M | 0.01% |
1,442,473
+458,396
| +47% | +$986K |
|
390
REE Automotive
REE
$18.9M
| $3.08M | 0.01% |
+1,159,750
| New | +$3.08M |
|
391
Cytokinetics
CYTK
$6.34B
| $3.01M | 0.01% |
75,000
-75,000
| -50% | -$3.01M |
|
392
NuScale Power
SMR
$4.62B
| $3.01M | 0.01% |
212,716
-212,715
| -50% | -$3.01M |
|
393
Avidity Biosciences
RNA
$6.48B
| $2.95M | 0.01% |
100,000
+50,000
| +100% | +$1.48M |
|
394
Merus
MRUS
$5.1B
| $2.87M | 0.01% |
68,182
-68,182
| -50% | -$2.87M |
|
395
Cenovus Energy
CVE
$28.7B
| $2.85M | 0.01% |
+204,786
| New | +$2.85M |
|
396
Lucid Diagnostics
LUCD
$140M
| $2.81M | 0.01% |
+1,887,843
| New | +$2.81M |
|
|
TLN
397
Talen Energy Corporation Common Stock
TLN
$17.8B
| $2.81M | 0.01% |
14,074
-85,482
| -86% | -$17.1M |
|
398
Evolus
EOLS
$495M
| $2.71M | 0.01% |
225,000
-100,000
| -31% | -$1.2M |
|
399
Amylyx Pharmaceuticals
AMLX
$910M
| $2.66M | 0.01% |
750,412
-73,008
| -9% | -$258K |
|
400
AerSale
ASLE
$402M
| $2.59M | 0.01% |
346,411
-753,589
| -69% | -$5.64M |
|